Investment Partners

Will brings over thirty years of early stage company building experience as a CEO of several start-ups and as an early stage venture investor.

Will co-founded Long River Ventures in 2000 and has served as a General Partner in all three Long River Ventures funds with a total of $70 million under management. Will focuses on healthcare investments. He serves, or has served, on the boards of numerous companies including Carevive Systems, Convergent Dental, Edaris Health, GetWellNetwork, Healthrageous, lifeIMAGE, Medical Metrx Systems, MedVentive, Oculus Health, Parsagen Diagnostics, Phreesia, Solais, and Verax Biomedical.

Prior to Long River, Will founded NaviNet with backing from North Bridge, Atlas Venture, and GE Equities. NaviNet grew to be a leading healthcare IT firm that streamlined transactions between healthcare payers and over 800,000 healthcare providers. Prior to NaviNet, Will was CEO of venture-backed Pegasus Medical Technologies, an electronic medical records company sold to HBOC/McKesson (NYSE:MCK). Early in his career, Will was a founder and VP/Business Development at consumer products company, Thermocell, which is today a $500 million dollar division of the Hunter Douglas Company. On the investing side, Will was a Managing Partner of Interface Technologies and Firepond Partners, two early stage healthcare funds. Will holds a B.A. from the University of Colorado and an M.B.A. from the Massachusetts Institute of Technology.

Keith brings deep and extensive experience in healthcare informatics in multiple roles overseeing enterprise healthcare technology initiatives.

Keith J. Figlioli was most recently Premier, Inc.’s Senior Vice President of healthcare informatics. In this role, he oversaw the company’s enterprise healthcare technology business unit spanning strategy, sales, marketing, client support, development, delivery, and operations. He created the vision for and built the company’s enterprise performance improvement platform called PremierConnect and extended its capabilities through acquisitions and strategic investments including CECity, Theradoc, Aperek, Meddius, Healthcare Insights, and Inflow Health. As a member of the executive leadership team, he helped the company and its health system members raise $820 million in its IPO. He co-chaired Premier’s Member Technology Improvement Committee, a subcommittee of Premier’s board of directors that plays a vital role in setting direction for the alliance by collaborating with health systems to improve care delivery and the health of communities through technology.

Prior to Premier, Keith was with Eclipsys (acquired by Allscripts) as its Senior Vice President of Enterprise Solutions, where he was responsible for all go-to-market activities, market planning, and solution strategic direction across clinical, financial, and operational product offerings. During his tenure at Eclipsys, he served in several roles. He was Vice President and general manager of Revenue Cycle / Performance Improvement solutions, where he managed the growth of the Eclipsys revenue cycle, decision support, and departmental solution portfolio, including business growth and market planning, and coordination of functional leadership to drive solution outcomes and customer satisfaction. He was Vice President of International operations, during which time he built the company’s first international operation in India. And he served as Vice President of corporate development where he owned the annual strategic planning process, mergers and acquisitions, strategic partnership development, and spearheaded new business initiatives focusing on performance improvement, clinical trials and clinical content markets.

Earlier in his career, Keith was the senior business development executive at a management consulting and systems integration company focusing on Fortune 1000 companies and previously served in a variety of business development and marketing roles within the health information technology industry including work for Per-Se Technologies, Medaphis and NEC. Keith has an M.B.A. from Boston University and a B.A. from Wheaton College. He is a member of the Board of Trustees at Wheaton College, founder and executive chairman of Censinet, Inc, a board observer of Cyft, Intelycare, and Diameter Health, and a strategic advisor for the SMART on FHIR platform initiative. He has previously served on the Health IT Standards Committee for the Office of the National Coordinator and the board of directors for Global Healthcare Exchange (GHX), Activate Networks, Good Sports, and MassBike.

John is an experienced investor who focuses on information technology for the funds.

John Kole has worked with the Long River Ventures team since 2009 as an advisor and Venture Partner, and then joined Long River Ventures III as a General Partner. John invests in tech companies with a particular focus on internet, mobile, media, and IT infrastructure. John also leads technical due diligence for all of Long River’s investment. He currently serves as a board member of Device42.

Prior to joining Long River Ventures, John was President of Merrimack Capital LLC, a privately owned investment fund. Previously, John was a Managing Director and founding General Partner of Comcast Interactive Capital (CIC), a $350 million venture capital fund sponsored by Comcast Corporation. At CIC, John was responsible for investments in technology start-ups across a variety of sectors, from cable and telecommunications infrastructure to enterprise software and internet commerce and content. Before joining CIC, John worked as an investment banker in Credit Suisse First Boston's Media and Telecommunications group, and as a mergers and acquisitions attorney at Davis Polk & Wardwell. John is a CFA charterholder and earned his J.D from the University of Michigan Law School, and his B.A. from Princeton University's Woodrow Wilson School of Public and International Affairs.

Tripp brings over thirty years of company building and venture investing experience to the funds.

Tripp Peake co-founded Long River Ventures in 2000 and has served as a General Partner in all three Long River Ventures funds with a total of $70 million under management. Tripp invests primarily in B2B software and internet companies in a range of sectors including media, telecom, business services, and healthcare. He has been lead investor and/or board member at numerous companies including Diameter Health, Extreme Reach, Health Guru (acquired by Kitara Media), Machine Metrics, Optasite (acquired by SBA Communications), Profile Systems (acquired by Comergent), Protedyne (acquired by LabCorp), Sovereign Hill Software (acquired by Dataware), and Western Mass Radio Group (acquired by Pamal Broadcasting).

Immediately prior to Long River, Tripp was a partner at Kestrel Venture Management, where he focused on the management of the Mass Ventures Equity Fund, a $14 million early stage fund established in western Massachusetts in 1997. Before joining Kestrel, Tripp was co-founder and CEO of two venture development consulting companies: Mass Ventures, based in Amherst, MA and associated with the University of Massachusetts; and Science Park Associates, based in New Haven, CT and associated with Yale University. Both of these companies provided university spin-offs and regional entrepreneurs with strategic and financing advice and helped raise over $50 million in private equity for 18 different early stage ventures. Tripp holds a B.A. from Dartmouth College and an M.B.A from Yale University.


Executive Advisors

  • Chairman, xG Health Solutions
  • Former President and CEO, Geisinger
  • Vice Chairman, Health Transformation Alliance
  • Former Dean of the Biological Sciences Division and the Pritzker School of Medicine and Vice President for Medical Affairs at the University of Chicago
  • CEO of Acelity
  • Board Chair, Varian Medical
  • Board Member, Becton Dickinson (BD)
  • Former CEO of Valence Health, CRC Health, Trizetto, Eclipsys
  • President and CEO, Mass eHealth Collaborative
  • Former President and CEO, Indiana Health Information Exchange
  • Former Manager, Boston Consulting Group
  • Former Sr. VP, Corporate Development and Strategy, Premier, Inc.
  • Former Chief Development Officer, AMI
  • Former Partner, Ernst & Young

Industry Advisors

  • Randy Barko

    Executive Director and Former CEO, Ximedica

  • Dr. Hans Boerma

    Managing Partner, KBT Partners

    SVP Products, Eclipsys (acquired by Allscripts)

  • Dr. Peter Bonis

    Chief Medical Officer, Wolters Kluwer Health

    Clinical professor of Medicine,

    Tufts School of Medicine

  • Paul Brient

    President and CEO, Patientkeeper

    Former SVP, McKesson

  • John Brooks

    Managing Director, Healthcare Capital

    Former President and CEO, Joslin Diabetes Center

  • Mike Cataldo

    CEO, Convergent Dental

    Former EVP, McKesson

    Founder/CEO MediVation

  • Peter Durlach

    SVP Marketing and Strategy, Nuance

    Executive in Residence, UPMC

    President, Unveil Technologies

  • Nancy Ham

    CEO, WebPT

    Former CEO, Medicity/Healthagen,

    Medventive, Sentillion

  • Michael Kaufman

    Managing Partner, KBT Partners

    Former SVP Business Development, Eclipsys (acquired by Allscripts)

  • TemiTuoyo Louis

    Chief Operating Officer and

    Managing Director, Zaffre Investments

    Former Director of New Ventures,

    Blue Cross Blue Shield of Massachusetts

  • Mike O’Neil

    Founder and CEO, GetWellNetwork

  • Dr. Marlon Priest

    Former Executive Vice President and Chief Medical Officer, Bon Secours Health System

    Former Professor of Emergency Medicine and Surgery, University of Alabama Birmingham

  • Russ Rudish

    Founder/CEO, Rudish Health Solutions

    Former Partner, Deloitte Healthcare

  • Ruben Salinas

    Founder and CEO, Rudish Health Solutions

    Executive Vice President and General Manager, QIAGEN

  • Ric Speaker

    Executive Advisor, Commonwealth Health Advisors

    Former General Manager, IDX Systems

  • Joel Vengco

    SVP and CIO, Baystate Health

    VP and General Manager, GE Healthcare

  • Michael Weintraub

    Former CEO, Optum Analytics (formerly, Humedica)

    Former Founder, CEO, PharMetrics